Serum cAMP levels are increased in patients with asthma
J Clin Invest
.
2025 Jan 7;135(5):e186937.
doi: 10.1172/JCI186937.
Authors
Steven S An
1
,
Gaoyuan Cao
1
,
Kwangmi Ahn
2
,
Jordan Lee
1
,
Dae Young Jung
1
,
Loren Denlinger
3
,
John Fahy
4
,
Elliot Israel
5
,
Wendy Moore
6
,
Brenda Phillips
7
,
David Mauger
7
,
Sally Wenzel
8
,
Reynold A Panettieri Jr
1
Affiliations
1
Rutgers Institute for Translational Medicine and Science, New Brunswick, New Jersey, USA.
2
National Human Genome Research Institute, Bethesda, Maryland, USA.
3
Division of Allergy, Pulmonary and Critical Care Medicine, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
4
Cardiovascular Research Institute, UCSF, San Francisco, California, USA.
5
Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
6
Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
7
Pennsylvania State University, Hershey, Pennsylvania, USA.
8
Department of Environmental and Occupational Health, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA.
PMID:
39774028
PMCID:
PMC11870724
DOI:
10.1172/JCI186937
No abstract available
Keywords:
Asthma; Cell biology; Cyclic nucleotides; G protein–coupled receptors; Pulmonology.
Grants and funding
P01 HL114471/HL/NHLBI NIH HHS/United States
P30 ES005022/ES/NIEHS NIH HHS/United States
R01 HL164404/HL/NHLBI NIH HHS/United States